#Pharmaceuticals
Latest news articles tagged with "Pharmaceuticals". Follow the timeline of events, related topics, and entities.
Articles (30)
-
🇺🇸 Earnings call transcript: Amphastar’s Q4 2025 Misses Estimates, Stock Dips
[USA]
Related: #Corporate Earnings, #Stock Market, #Financial Analysis
-
🇺🇸 Buy this best-in-class GLP-1 leader as competition heats up, says Barclays
[USA]
Barclays' $1,350 price target implies upside of 32%.
Related: #Investment Recommendations, #Market Competition -
🇺🇸 Recordati shares edge up as FY25 results meet expectations, FY26 outlook solid
[USA]
Related: #Earnings, #Investment, #Stock Market
-
🇺🇸 Sanofi stock rating downgraded to Neutral by BofA on CEO transition
[USA]
Related: #Economy, #Finance
-
🇺🇸 Ipsen shares jump as 2026 guidance exceeds expectations
[USA]
Related: #Finance, #Stock Market
-
🇺🇸 Neurocrine earnings beat by $0.02, revenue topped estimates
[USA]
Related: #Finance, #Earnings
-
🇺🇸 Upstream Bio stock tumbles after mixed Phase 2 asthma trial results
[USA]
Related: #Biotechnology, #Financial Markets
-
🇺🇸 Form 144 MERCK & CO. For: 10 February
[USA]
Related: #Corporate Governance, #Finance
-
🇺🇸 Pfizer stock hits 52-week high at 27.7 USD
[USA]
Related: #Finance, #Stock Market
-
🇺🇸 GSK’s Arexvy RSV vaccine accepted for regulatory review in China
[USA]
Related: #Public Health, #Global Trade
-
🇺🇸 Progressive Multi-Agent Reasoning for Biological Perturbation Prediction
[USA]
arXiv:2602.07408v1 Announce Type: new Abstract: Predicting gene regulation responses to biological perturbations requires reasoning about underlying biological causalities. While large language model...
Related: #Artificial Intelligence, #Biotechnology -
🇺🇸 India’s Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US
[USA]
Related: #Intellectual Property, #International Trade
-
🇺🇸 AstraZeneca earnings up next after NYSE debut, China expansion
[USA]
Related: #Global Economy, #Corporate Finance
-
🇺🇸 Hims to stop offering GLP-1 pill after FDA warned of crackdown
[USA]
Related: #Regulation, #Healthcare
-
🇺🇸 Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Feb. 8, 2026
[USA]
The following is the transcript of the interview with Dr. Scott Gottlieb, former FDA commissioner, that aired on "Face the Nation with Margaret Brennan" on Feb. 8, 2026. Dr. Gottlieb also sits on the ...
Related: #Public Health, #Government Policy -
🇺🇸 Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill
[USA]
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug
Related: #Healthcare, #Business -
🇺🇸 Hims & Hers Withdraws Knockoff Weight-Loss Pill After Regulatory Scrutiny
[USA]
Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.
Related: #Healthcare Regulation, #Telehealth -
🇺🇸 Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
[USA]
Related: #Healthcare Regulation, #Business Finance
-
🇺🇸 See the 43 drugs available on new discounted drug site TrumpRx
[USA]
Here's what to know about TrumpRx, including how it works, who can use it, and how much money it can save.
Related: #Healthcare, #Economy -
🇺🇸 Bernstein reiterates Eli Lilly stock rating at Outperform with $1,300 target
[USA]
Related: #Finance, #Stock Market
-
🇺🇸 Eli Lilly stock price target raised to $1,300 by BMO Capital
[USA]
Related: #Finance, #Healthcare
-
🇺🇸 Teen who admitted shooting 2 friends claims acne medication gave him homicidal thoughts
[USA]
A Texas teenager was arrested after he admitted to shooting two of his friends in 2023. One of the friends died and the teen blamed his actions on an acne medication, claiming it gave him homicidal th...
Related: #Criminal Justice, #Mental Health -
🇺🇸 Clearmind Medicine stock surges after Polyrizon intranasal delivery deal
[USA]
Related: #Biotechnology, #Stock Market, #Medical Innovation
-
🇺🇸 Trump unveils TrumpRx discounted drugs website
[USA]
Related: #Healthcare Policy, #Economy
-
🇺🇸 Merck forecasts 2026 sales below estimates on patent losses
[USA]
Related: #Economy, #Finance
-
🇺🇸 Merck&Co earnings matched, revenue topped estimates
[USA]
Related: #Finance, #Corporate Earnings
-
🇺🇸 Quince Therapeutics stock rating downgraded by Citizens after Phase 3 trial failure
[USA]
Related: #Biotechnology, #Finance
-
🇺🇸 Vaxcyte prices $550 million public offering of common stock
[USA]
Related: #Biotechnology, #Finance
-
🇺🇸 Form 13D/A NovaBay Pharmaceuticals For: 29 January
[USA]
Related: #Finance, #Regulation
-
🇺🇸 Could weight-loss jabs be behind rising gallbladder removals?
[USA]
Last year, there was a 15% annual increase in the operations and surgeons want more research.
Related: #Healthcare, #Medicine, #Public Health